Fig. 1From: Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system© Bioactive material 2022a The scheme of the mEHGZ NPs induced IMT-relevant cancer synergistic therapy. b Flow cytometry results of the membrane encapsulation efficiency on mEHGZ NPs. c Scheme of ICD triggering the release of antigens and DAMPs. d Percentage of CD8 + T cells in tumor tissue after different treatments [69], copyrightBack to article page